{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-099740","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2025-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.506766+00:00","generated_at":"2026-05-17T03:43:21.262060+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Carisma Therapeutics terminates CEO (eff. Nov 15) and CSO; three directors resign","bullets":["CEO Steven Kelly terminated without cause, effective Nov 15, 2025; gets $624K severance plus $299,948 prorated bonus and health payments.","CSO Michael Klichinsky terminated without cause, effective Oct 15, 2025; receives 12 months salary in installments, prorated bonus, $2,245/month health payment.","Directors John Hohneker, Briggs Morrison, David Scadden resigned Oct 15; Kelly resigns from board effective Nov 15.","Company will appoint a consultant as CEO to manage wind-down; prior retention bonus agreement with Kelly voided.","Wind-down of operations previously disclosed; no disagreement cited for director resignations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-099740","json":"https://secwatch.observer/filing/0001104659-25-099740.json","markdown":"https://secwatch.observer/filing/0001104659-25-099740.md","text":"https://secwatch.observer/filing/0001104659-25-099740.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465925099740/0001104659-25-099740-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465925099740/tm2528741d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:43:21.262060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}